Change

Consolidated balance sheet


 

In € millions, December 31

 

 

 

 

2000

2001

2002

20031

2004

20052

2006

2007

2008

2009

1

The 2000 – 2003 figures have not been restated to IFRS accounting standards. The differences mainly relate to pensions and other post-retirement benefits, the recognition of deferred taxes on intercompany profit, and the recognition of goodwill.

2

The 2000 – 2005 figures have not been restated for the Organon BioSciences divestment.

3

Not meaningful due to the temporary net cash position.

 

 

 

 

 

 

 

 

 

 

 

 

Intangible assets

388

508

629

590

448

488

682

669

7,172

7,388

Property, plant and equipment

4,501

4,568

4,402

3,967

3,535

3,432

3,346

2,203

3,357

3,474

Financial non-current assets

2,000

1,895

2,217

1,866

1,418

1,800

1,706

1,402

1,848

1,783

Total non-current assets

6,889

6,971

7,248

6,423

5,401

5,720

5,734

4,274

12,377

12,645

 

 

 

 

 

 

 

 

 

 

 

 

Inventories

2,267

2,270

2,206

2,133

1,978

1,987

2,042

1,177

1,781

1,441

Receivables

3,135

3,229

2,815

2,671

2,761

2,910

2,919

2,164

2,977

2,666

Cash and cash equivalents

416

455

520

727

1,811

1,486

1,871

11,628

1,595

2,128

Assets held for sale

322

219

4

Total current assets

5,818

5,954

5,541

5,531

6,550

6,705

7,051

14,969

6,357

6,235

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity

2,694

2,878

2,098

2,502

2,605

3,415

4,144

11,032

7,463

7,775

Minority interests

159

138

137

140

140

161

119

97

450

470

Total equity

2,853

3,016

2,235

2,642

2,745

3,576

4,263

11,129

7,913

8,245

 

 

 

 

 

 

 

 

 

 

 

 

Provisions

2,279

2,400

3,855

3,333

2,877

2,210

2,132

1,598

2,072

1,919

Long-term borrowings

2,729

2,235

2,797

2,717

2,392

2,702

2,551

1,954

2,341

3,641

Other non-current liabilities

518

560

513

590

200

183

181

133

715

674

Total non-current liabilities

5,526

5,195

7,165

6,640

5,469

5,095

4,864

3,685

5,128

6,234

 

 

 

 

 

 

 

 

 

 

 

 

Short-term borrowings

1,967

2,267

979

441

560

357

410

1,635

1,338

384

Current liabilities

2,361

2,447

2,410

2,231

2,677

2,571

2,652

2,276

3,510

3,220

Current portion of provisions

500

766

571

518

845

797

Liabilities held for sale

60

25

Total current liabilities

4,328

4,714

3,389

2,672

3,737

3,754

3,658

4,429

5,693

4,401

 

 

 

 

 

 

 

 

 

 

 

 

Invested capital:

 

 

 

 

 

 

 

 

 

 

-

Of consolidated companies

9,257

9,395

8,692

8,117

7,145

8,007

8,060

5,197

13,424

13,204

-

Of investments in associates and joint ventures

673

575

491

353

318

301

177

142

201

175

 

 

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment:

 

 

 

 

 

 

 

 

 

 

-

Capital expenditures

725

822

689

581

551

514

371

359

534

534

-

Depreciation

631

635

622

599

540

528

349

330

453

458

 

 

 

 

 

 

 

 

 

 

 

 

Ratios:

 

 

 

 

 

 

 

 

 

 

-

Revenue/invested capital

1.58

1.52

1.55

1.56

1.68

1.68

1.85

1.91

1.07

1.04

-

Gearing

1.50

1.34

1.46

0.92

0.42

0.44

0.26

3

0.26

0.21

-

Equity/non-current assets

0.41

0.43

0.31

0.41

0.51

0.62

0.74

2.60

0.64

0.65

-

Inventories and receivables/current liabilities

2.29

2.25

2.08

2.15

1.77

1.9

1.87

1.47

1.36

1.28

For definitions of certain financial ratios and concepts see the full glossary.

Keyword Search
Copyright © 2010 Akzo Nobel N.V.